Paper42864360PubMed
In vivo CRISPR screens identify dual functions of DNMT3A in mediating tumor immune evasion.
Zhao J and 12 others. Nat Commun, 2026.
Cite this record
ConductScience Library. In vivo CRISPR screens identify dual functions of DNMT3A in mediating tumor immune evasion. Papers, record 42864360. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42864360
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In vivo CRISPR screens identify dual functions of DNMT3A in mediating tumor immune evasion.
- Journal
- Nat Commun
- Year
- 2026
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't
- Revised in PubMed
- 2026-10-15
Source PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA (Cytosine-5-)-Methyltransferases | Major topic |
| Tumor Escape | Major topic |
| Neoplasms | Major topic |
| Animals | |
| DNA Methyltransferase 3A | |
| Female | |
| Mice | |
| CRISPR-Cas Systems | |
| Humans | |
| Cell Line, Tumor | |
| Cholesterol | |
| CD8-Positive T-Lymphocytes | |
| Immunotherapy | |
| Mice, Inbred C57BL | |
| Gene Expression Regulation, Neoplastic |
Source PubMed
References68
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26673418 | Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR. | Genome Biol | 2015 | https://conductscience.org/library/papers/26673418 | PubMed |
| 2 | 35216676 | Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer. | Cancer Cell | 2022 | https://conductscience.org/library/papers/35216676 | PubMed |
| 3 | 33953401 | Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity. | Nature | 2021 | https://conductscience.org/library/papers/33953401 | PubMed |
| 4 | 33827976 | A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma. | Sci Transl Med | 2021 | https://conductscience.org/library/papers/33827976 | PubMed |
| 5 | 40068600 | Targeting tumor monocyte-intrinsic PD-L1 by rewiring STING signaling and enhancing STING agonist therapy. | Cancer Cell | 2025 | https://conductscience.org/library/papers/40068600 | PubMed |
| 6 | 40983666 | The immune microenvironment of colorectal cancer. | Nat Rev Cancer | 2025 | https://conductscience.org/library/papers/40983666 | PubMed |
| 7 | 39819598 | Tissue-specific roles of de novo DNA methyltransferases. | Epigenetics Chromatin | 2025 | https://conductscience.org/library/papers/39819598 | PubMed |
| 8 | 31848472 | Mechanisms and regulation of cholesterol homeostasis. | Nat Rev Mol Cell Biol | 2020 | https://conductscience.org/library/papers/31848472 | PubMed |
| 9 | 31548600 | The emerging role of epigenetic therapeutics in immuno-oncology. | Nat Rev Clin Oncol | 2020 | https://conductscience.org/library/papers/31548600 | PubMed |
| 10 | 40911779 | ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion. | Cancer Res | 2025 | https://conductscience.org/library/papers/40911779 | PubMed |
| 11 | 33910046 | Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance. | Cell Metab | 2021 | https://conductscience.org/library/papers/33910046 | PubMed |
| 12 | 27562463 | The interplay between cell signalling and the mevalonate pathway in cancer. | Nat Rev Cancer | 2016 | https://conductscience.org/library/papers/27562463 | PubMed |
| 13 | 27240213 | Methyltransferase Dnmt3a upregulates HDAC9 to deacetylate the kinase TBK1 for activation of antiviral innate immunity. | Nat Immunol | 2016 | https://conductscience.org/library/papers/27240213 | PubMed |
| 14 | 24478339 | Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. | Bioinformatics | 2014 | https://conductscience.org/library/papers/24478339 | PubMed |
| 15 | 39500328 | Non-invasive lipid panel of MASLD fibrosis transition underscores the role of lipoprotein sulfatides in hepatic immunomodulation. | Cell Metab | 2025 | https://conductscience.org/library/papers/39500328 | PubMed |
| 16 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 17 | 25516281 | Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. | Genome Biol | 2014 | https://conductscience.org/library/papers/25516281 | PubMed |
| 18 | 40307212 | Inhibition of MBTPS1 enhances antitumor immunity and potentiates anti-PD-1 immunotherapy. | Nat Commun | 2025 | https://conductscience.org/library/papers/40307212 | PubMed |
| 19 | 32694690 | Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities. | Nat Metab | 2020 | https://conductscience.org/library/papers/32694690 | PubMed |
| 20 | 32080181 | Collaborative interactions of heterogenous ribonucleoproteins contribute to transcriptional regulation of sterol metabolism in mice. | Nat Commun | 2020 | https://conductscience.org/library/papers/32080181 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42864360
GET https://conductscience.org/api/papers/v1/42864360/references?page=2